Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

23 November 2016

Suzanne Wolf discusses new 2016 Access to Medicine Index on NOS Radio 1 Journaal

Dutch national news radio covers the findings of the fifth Access to Medicine Index, published on 14 November, 2016 (Dutch language).

Writing for Intellectual Property Watch, Catherine Saez reports on the main findings of the 2016 Access to Medicine Index, focusing on its overal analysis of how the industry approaches the international agreement on the Trade Related Aspects of Intellectual Property Rights (TRIPS) and compulsory licences.The item reports from pharmacies in Kenya, where rural communities continue to face barriers to access to medicine. Suzanne Wolf, Director of Communications, discusses the Index analysis of companies’ pricing strategies, touching on the complex factors that contribute to the final price of a medicine for patients in low- and middle-income countries.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved